Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage Academic Article uri icon

Overview

MeSH Major

  • Anticoagulants
  • Antithrombin Proteins
  • Benzimidazoles
  • Cerebral Hemorrhage
  • Hematoma
  • Pyridines

abstract

  • In contrast with warfarin, pretreatment with DE did not increase hematoma volume in 2 different experimental models of ICH. In terms of safety, this observation may represent a potential advantage of anticoagulation with DE over warfarin.

publication date

  • October 11, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3724228

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.111.035972

PubMed ID

  • 21911784

Additional Document Info

start page

  • 1654

end page

  • 62

volume

  • 124

number

  • 15